TFF PHARMACEUTICALS, INC. Lease, Cost
TFF PHARMACEUTICALS, INC. reported Lease, Cost of $42.06 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. lease, cost for the quarter ending 2024-09-30 was $42.06K, a 4.07% decline year-over-year.
- TFF PHARMACEUTICALS, INC. lease, cost for the quarter ending 2024-06-30 was $42.98K, a 1.97% decline year-over-year.
- TFF PHARMACEUTICALS, INC. lease, cost for the quarter ending 2023-09-30 was $43.84K, a 11.46% decline year-over-year.
- TFF PHARMACEUTICALS, INC. lease, cost for the quarter ending 2023-06-30 was $43.84K, a 26.83% increase year-over-year.
- TFF PHARMACEUTICALS, INC. lease, cost for fiscal 2022 was $156.66K, a 100.85% increase from fiscal 2021.
- TFF PHARMACEUTICALS, INC. lease, cost for fiscal 2021 was $78.00K.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $42.06K 10-Q · filed 2024-11-20 | $85.04K derived: sum of 2 quarters · filed 2024-11-20 | $128.63K 10-Q · filed 2024-11-20 | ||
| 2024-06-30 | $42.98K 10-Q · filed 2024-08-14 | $85.89K 10-Q · filed 2024-08-14 | |||
| 2023-09-30 | $43.84K 10-Q · filed 2024-11-20 | $87.69K derived: sum of 2 quarters · filed 2024-11-20 | $131.74K 10-Q · filed 2024-11-20 | $177.30K derived: sum of 4 quarters · filed 2024-11-20 | |
| 2023-06-30 | $43.84K 10-Q · filed 2024-08-14 | $87.89K 10-Q · filed 2024-08-14 | $133.46K derived: sum of 3 quarters · filed 2024-08-14 | $182.98K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $44.05K 10-Q · filed 2023-05-11 | $89.61K derived: sum of 2 quarters · filed 2023-05-11 | $139.13K derived: sum of 3 quarters · filed 2023-11-14 | $173.70K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-12-31 | $45.57K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $95.09K derived: sum of 2 quarters · filed 2023-11-14 | $129.66K derived: sum of 3 quarters · filed 2023-11-14 | $156.66K 10-K · filed 2023-03-31 | |
| 2022-09-30 | $49.52K 10-Q · filed 2023-11-14 | $84.09K derived: sum of 2 quarters · filed 2023-11-14 | $111.09K 10-Q · filed 2023-11-14 | $135.09K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $34.57K 10-Q · filed 2023-08-14 | $61.51K 10-Q · filed 2023-08-14 | $85.57K derived: sum of 3 quarters · filed 2023-08-14 | $105.57K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $27.00K 10-Q · filed 2023-05-11 | $51.00K derived: sum of 2 quarters · filed 2023-05-11 | $71.00K derived: sum of 3 quarters · filed 2023-05-11 | $91.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $44.00K derived: sum of 2 quarters · filed 2023-03-31 | $64.00K derived: sum of 3 quarters · filed 2023-03-31 | $78.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $40.00K derived: sum of 2 quarters · filed 2022-11-14 | $54.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $20.00K 10-Q · filed 2022-11-14 | $19.00K 10-Q · filed 2022-08-11 | $34.00K 10-Q · filed 2022-08-11 |